======= EPC1 ======= == Gene Information == * **Official Symbol**: EPC1 * **Official Name**: enhancer of polycomb homolog 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=80314|80314]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9H2F5|Q9H2F5]] * **Interactions**: [[https://thebiogrid.org/search.php?search=EPC1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20EPC1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/610999|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: N/A |E Pc C| |EPL1| |Piccolo NuA4 histone acetyltransferase complex| |vascular smooth muscle cell differentiation| |histone H2A acetylation| |NuA4 histone acetyltransferase complex| |smooth muscle cell differentiation| |negative regulation of G0 to G1 transition| |regulation of G0 to G1 transition| |histone acetyltransferase activity| |histone H4 acetylation| |negative regulation of gene expression, epigenetic| |histone acetylation| |internal peptidyl-lysine acetylation| |peptidyl-lysine acetylation| |internal protein amino acid acetylation| |protein acetylation| |protein acylation| |regulation of gene expression, epigenetic| |nuclear membrane| |muscle cell differentiation| |peptidyl-lysine modification| |negative regulation of cell cycle process| |histone modification| |covalent chromatin modification| |muscle structure development| |vasculature development| |cardiovascular system development| |negative regulation of cell cycle| |transcription, DNA-templated| |nucleic acid-templated transcription| |RNA biosynthetic process| |regulation of growth| |chromatin organization| |regulation of cell cycle process| |negative regulation of transcription by RNA polymerase II| |circulatory system development| |peptidyl-amino acid modification| |chromosome organization| |nucleobase-containing compound biosynthetic process| |heterocycle biosynthetic process| |aromatic compound biosynthetic process| |regulation of cell cycle| |negative regulation of transcription, DNA-templated| |positive regulation of transcription by RNA polymerase II| |negative regulation of nucleic acid-templated transcription| |negative regulation of RNA biosynthetic process| |organic cyclic compound biosynthetic process| |negative regulation of RNA metabolic process| |negative regulation of cellular macromolecule biosynthetic process| |negative regulation of nucleobase-containing compound metabolic process| |negative regulation of macromolecule biosynthetic process| |negative regulation of cellular biosynthetic process| |positive regulation of transcription, DNA-templated| |negative regulation of biosynthetic process| |cellular nitrogen compound biosynthetic process| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |RNA metabolic process| |cellular macromolecule biosynthetic process| |negative regulation of gene expression| |positive regulation of RNA metabolic process| |macromolecule biosynthetic process| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp435|JQ1 0.8μM R08 exp435]]|-2.43| |[[:results:exp6|Bortezomib 0.005μM R00 exp6]]|-2.09| |[[:results:exp220|BAY-598 4μM R05 exp220]]|-1.71| |[[:results:exp226|Cerivastatin 0.15μM R05 exp226]]|1.7| |[[:results:exp81|Selumetinib 20μM R02 exp81]]|1.74| |[[:results:exp106|UM131593 0.2μM R03 exp106]]|1.77| |[[:results:exp84|UM0125461 0.74μM R02 exp84]]|1.79| |[[:results:exp79|Q15 2.7μM R02 exp79]]|2.09| |[[:results:exp214|2-Deoxy-D-glucose 800μM R05 exp214]]|2.26| |[[:results:exp75|MK-1775 0.32μM R02 exp75]]|2.43| |[[:results:exp416|Tubacin 1.6μM R07 exp416]]|2.65| |[[:results:exp34|Rotenone 20μM R00 exp34]]|2.76| ^Gene^Correlation^ |[[:human genes:e:epc2|EPC2]]|0.479| Global Fraction of Cell Lines Where Essential: 8/726 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|1/28| |blood|0/28| |bone|0/25| |breast|1/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|1/15| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|1/14| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|2/15| |prostate|0/1| |skin|0/24| |soft tissue|0/7| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 2941 * **Expression level (log2 read counts)**: 6.17 {{:chemogenomics:nalm6 dist.png?nolink |}}